Congress temporarily suspends tariffs on imported formula to reduce cost
The Senate today passed and sent to the president for his signature the Formula Act (H.R. 8351), bipartisan legislation that would suspend tariffs on imported infant formula through 2022. The Food and Drug Administration has allowed formula imports to help address a U.S. formula shortage, but tariffs have increased the retail cost of these products. The Department of Health and Human Services offers a webpage to help health care providers and families locate formula.
Related News Articles
Headline
The results of a study published July 16 by JAMA Network Open showed a 19% increase in postpartum primary care provider visits for patients through the use of…
Headline
Kittitas Valley Healthcare, based in Ellensburg, Wash., was delivering 300-350 babies each year in the region prior to 2022, offering the area’s only…
Headline
An infographic released by the University of Minnesota Rural Health Research Center highlights the decline of maternity care access in rural counties across…
Headline
The Health Resources and Services Administration June 11 announced that Montana is eligible for $5.4 million in federal funding this year for the Maternal,…
Headline
The award-winning Beyond Birth podcast series helps bring hospital programs to life by telling personal stories of how they positively impact mothers and their…
Blog
Our health may be the most personal and important thing we have. It determines how we feel when we wake up in the morning, how we relate to our families and…